Hourglass Capital’s Colgate-Palmolive CL Stock Holding History

Hourglass Capital’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$239K	Hold	2,800	–	–	0.05%	121
2025 Q4	$221K	Sell	2,800 -900	-24%	-$70.6K	0.05%	112
2025 Q3	$296K	Hold	3,700	–	–	0.07%	99
2025 Q2	$336K	Hold	3,700	–	–	0.08%	91
2025 Q1	$347K	Hold	3,700	–	–	0.09%	93
2024 Q4	$336K	Buy	3,700 +1,400	+61%	+$134K	0.09%	89
2024 Q3	$239K	Hold	2,300	–	–	0.07%	95
2024 Q2	$223K	Hold	2,300	–	–	0.07%	96
2024 Q1	$207K	Buy	+2,300	New	+$195K	0.06%	99
2022 Q2	–	Sell	-8,223	Closed	-$624K	–	108
2022 Q1	$624K	Sell	8,223 -380	-4%	-$30.1K	0.2%	74
2021 Q4	$734K	Sell	8,603 -600	-7%	-$46.9K	0.25%	73
2021 Q3	$696K	Sell	9,203 -100	-1%	-$7.94K	0.19%	79
2021 Q2	$757K	Sell	9,303 -20	-0.2%	-$1.64K	0.18%	89
2021 Q1	$735K	Sell	9,323 -125	-1%	-$9.8K	0.19%	87
2020 Q4	$808K	Hold	9,448	–	–	0.24%	68
2020 Q3	$729K	Hold	9,448	–	–	0.25%	60
2020 Q2	$692K	Sell	9,448 -350	-4%	-$24.9K	0.25%	60
2020 Q1	$650K	Hold	9,798	–	–	0.28%	59
2019 Q4	$674K	Hold	9,798	–	–	0.18%	65
2019 Q3	$720K	Sell	9,798 -400	-4%	-$29K	0.21%	60
2019 Q2	$731K	Hold	10,198	–	–	0.21%	59
2019 Q1	$699K	Sell	10,198 -700	-6%	-$45.2K	0.2%	58
2018 Q4	$649K	Sell	10,898 -200	-2%	-$12.5K	0.2%	62
2018 Q3	$743K	Sell	11,098 -410	-4%	-$27.3K	0.19%	60
2018 Q2	$746K	Sell	11,508 -80	-0.7%	-$5.23K	0.19%	60
2018 Q1	$831K	Sell	11,588 -490	-4%	-$35.3K	0.19%	66
2017 Q4	$911K	Hold	12,078	–	–	0.21%	66
2017 Q3	$880K	Sell	12,078 -1,100	-8%	-$79.3K	0.21%	63
2017 Q2	$977K	Sell	13,178 -1,645	-11%	-$122K	0.25%	62
2017 Q1	$1.08M	Hold	14,823	–	–	0.26%	62
2016 Q4	$970K	Sell	14,823 -6,434	-30%	-$441K	0.24%	62
2016 Q3	$1.58M	Sell	21,257 -70	-0.3%	-$5.17K	0.39%	59
2016 Q2	$1.56M	Sell	21,327 -270	-1%	-$19.2K	0.39%	60
2016 Q1	$1.53M	Sell	21,597 -800	-4%	-$53.2K	0.39%	59
2015 Q4	$1.49M	Hold	22,397	–	–	0.39%	61
2015 Q3	$1.42M	Sell	22,397 -80	-0.4%	-$5.23K	0.31%	63
2015 Q2	$1.47M	Sell	22,477 -2,410	-10%	-$163K	0.23%	69
2015 Q1	$1.73M	Sell	24,887 -50	-0.2%	-$3.46K	0.26%	69
2014 Q4	$1.73M	Sell	24,937 -400	-2%	-$27K	0.31%	71
2014 Q3	$1.65M	Sell	25,337 -853	-3%	-$56.3K	0.22%	74
2014 Q2	$1.79M	Sell	26,190 -3,210	-11%	-$215K	0.26%	74
2014 Q1	$1.91M	Sell	29,400 -300	-1%	-$18.9K	0.32%	75
2013 Q4	$1.94M	Sell	29,700 -300	-1%	-$19.2K	0.31%	71
2013 Q3	$1.78M	Sell	30,000 -5,200	-15%	-$308K	0.31%	73
2013 Q2	$2.02M	Buy	+35,200	New	+$2.09M	0.37%	73

Other funds holding CL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Hourglass Capital's CL Position: Q1 2026 in Review

Hourglass Capital held its Colgate-Palmolive (CL) position steady in Q1 2026 at 2,800 shares worth $239K. The position accounts for 0.05% of the portfolio, ranked #121.

Hourglass Capital first reported a position in CL in Q2 2013 and has held it in 45 quarters since. The position peaked at $2.02M in Q2 2013. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

Hourglass Capital held 2,800 shares of Colgate-Palmolive worth $239K as of Q1 2026.
Hourglass Capital left its Colgate-Palmolive share count unchanged in Q1 2026.
Colgate-Palmolive made up 0.05% of Hourglass Capital's portfolio in Q1 2026, its #121 holding.
Hourglass Capital first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 45 quarters since.
Hourglass Capital's Colgate-Palmolive position peaked at $2.02M in Q2 2013.
1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Hourglass Capital's 13F filing for Q1 2026, filed 4 May 2026.